(Q83431012)
Statements
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate (English)
P Mease
V Strand
L Shalamberidze
A Dimic
T Raskina
Li-An Xu
Y Liu
10 February 2012